Demonstrated Protocol, Last Modified on January 16, 2020, Permalink
A high percentage of non-viable cells may impact the targeted cell recovery in 10x Genomics® Single Cell Protocols. This Demonstrated Protocol outlines best practices for reducing the percentage of non-viable or dead cells from a single cell suspension.
This Protocol was demonstrated using peripheral blood mononuclear cells (PBMCs) and dissociated tissue cells from colorectal cancer (CRC) and clear cell renal carcinoma (CCRC) patients. However, it may be used as a basis for removing dead cells from other cell lines as well as other primary cells in preparation for use in 10x Genomics Single Cell Protocols.